# Consistency, Immunogenicity, and Safety of Three Batches of 15-valent Pneumococcal Conjugate Vaccine

> **NCT05939219** · NA · UNKNOWN · sponsor: **Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd** · enrollment: 2346 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** 15-valent pneumococcal conjugate vaccine 202210001
- **BIOLOGICAL:** 15-valent pneumococcal conjugate vaccineY202210002
- **BIOLOGICAL:** 15-valent pneumococcal conjugate vaccineY202210003
- **BIOLOGICAL:** 15-valent pneumococcal conjugate vaccineY202210004
- **BIOLOGICAL:** 13 valent pneumococcal polysaccharide conjugate vaccine

## Key facts

- **NCT ID:** NCT05939219
- **Lead sponsor:** Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-01
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 2346 (ESTIMATED)
- **Last updated:** 2023-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05939219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05939219, "Consistency, Immunogenicity, and Safety of Three Batches of 15-valent Pneumococcal Conjugate Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05939219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*